{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T17:53:38Z","timestamp":1790963618812,"version":"4.1.0"},"reference-count":159,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,8,1]],"date-time":"2016-08-01T00:00:00Z","timestamp":1470009600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100005010","name":"Associazione Italiana per la Ricerca sul Cancro","doi-asserted-by":"crossref","award":["692298"],"award-info":[{"award-number":["692298"]}],"id":[{"id":"10.13039\/501100005010","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Seminars in Cancer Biology"],"published-print":{"date-parts":[[2016,8]]},"DOI":"10.1016\/j.semcancer.2016.07.001","type":"journal-article","created":{"date-parts":[[2016,7,10]],"date-time":"2016-07-10T04:17:29Z","timestamp":1468124249000},"page":"15-25","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":77,"special_numbering":"C","title":["Toll-like receptors signaling: A complex network for NF-\u03baB activation in B-cell lymphoid malignancies"],"prefix":"10.1016","volume":"39","author":[{"given":"Stavroula","family":"Ntoufa","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Giovanna","family":"Vilia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kostas","family":"Stamatopoulos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paolo","family":"Ghia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marta","family":"Muzio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.semcancer.2016.07.001_bib0005","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1016\/0092-8674(85)90275-2","article-title":"Establishment of dorsal-ventral polarity in the Drosophila embryo: the induction of polarity by the Toll gene product","volume":"42","author":"Anderson","year":"1985","journal-title":"Cell"},{"key":"10.1016\/j.semcancer.2016.07.001_bib0010","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1016\/0092-8674(85)90274-0","article-title":"Establishment of dorsal-ventral polarity in the Drosophila embryo: genetic studies on the role of the Toll gene product","volume":"42","author":"Anderson","year":"1985","journal-title":"Cell"},{"key":"10.1016\/j.semcancer.2016.07.001_bib0015","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1016\/S0092-8674(00)80172-5","article-title":"The dorsoventral regulatory gene cassette sp\u00e4tzle\/Toll\/cactus controls the potent antifungal response in Drosophila adults","volume":"86","author":"Lemaitre","year":"1996","journal-title":"Cell"},{"key":"10.1016\/j.semcancer.2016.07.001_bib0020","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1038\/41131","article-title":"A human homologue of the Drosophila Toll protein signals activation of adaptive immunity","volume":"388","author":"Medzhitov","year":"1997","journal-title":"Nature"},{"key":"10.1016\/j.semcancer.2016.07.001_bib0025","doi-asserted-by":"crossref","first-page":"2085","DOI":"10.1126\/science.282.5396.2085","article-title":"Defective LPS signaling in C3H\/HeJ and C57BL\/10ScCr mice: mutations in Tlr4 gene","volume":"282","author":"Poltorak","year":"1998","journal-title":"Science"},{"key":"10.1016\/j.semcancer.2016.07.001_bib0030","doi-asserted-by":"crossref","first-page":"2942","DOI":"10.4049\/jimmunol.174.5.2942","article-title":"Human TLR10 is a functional receptor expressed by B cells and plasmacytoid dendritic cells, which activates gene transcription through MyD88","volume":"174","author":"Hasan","year":"2005","journal-title":"J. Immunol."},{"key":"10.1016\/j.semcancer.2016.07.001_bib0035","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1038\/nri3446","article-title":"The history of Toll-like receptors\u2014redefining innate immunity","volume":"13","author":"O'Neill","year":"2013","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.semcancer.2016.07.001_bib0040","doi-asserted-by":"crossref","first-page":"3749","DOI":"10.4049\/jimmunol.162.7.3749","article-title":"Cutting edge: toll-like receptor 4 (TLR4)-deficient mice are hyporesponsive to lipopolysaccharide: evidence for TLR4 as the Lps gene product","volume":"162","author":"Hoshino","year":"1999","journal-title":"J. Immunol."},{"key":"10.1016\/j.semcancer.2016.07.001_bib0045","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1016\/0092-8674(94)90283-6","article-title":"The product of the tobacco mosaic virus resistance gene N: similarity to toll and the interleukin-1 receptor","volume":"78","author":"Whitham","year":"1994","journal-title":"Cell"},{"key":"10.1016\/j.semcancer.2016.07.001_bib0050","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1038\/351355b0","article-title":"Drosophila toll and IL-1 receptor","volume":"351","author":"Gay","year":"1991","journal-title":"Nature"},{"key":"10.1016\/j.semcancer.2016.07.001_bib0055","unstructured":"T. Kawai, Toll-like receptor signaling pathways, (2014) 1\u20138. doi: 10.3389\/fimmu.2014.00461\/abstract."},{"key":"10.1016\/j.semcancer.2016.07.001_bib0060","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1038\/ni.1863","article-title":"The role of pattern-recognition receptors in innate immunity: update on Toll-like receptors","volume":"11","author":"Kawai","year":"2010","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.semcancer.2016.07.001_bib0065","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1002\/eji.200535744","article-title":"Toll-like receptor stimulation as a third signal required for activation of human naive B cells","volume":"36","author":"Ruprecht","year":"2006","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.semcancer.2016.07.001_bib0070","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1007\/s12026-014-8523-2","article-title":"Toll-like receptors and B cells: functions and mechanisms","volume":"59","author":"Buchta","year":"2014","journal-title":"Immunol. Res."},{"key":"10.1016\/j.semcancer.2016.07.001_bib0075","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1038\/nri3383","article-title":"Marginal zone B cells: virtues of innate-like antibody-producing lymphocytes","volume":"13","author":"Cerutti","year":"2013","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.semcancer.2016.07.001_bib0080","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1172\/JCI117022","article-title":"Lipopolysaccharide (LPS)-binding protein and soluble CD14 function as accessory molecules for LPS-induced changes in endothelial barrier function, in vitro","volume":"93","author":"Goldblum","year":"1994","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.semcancer.2016.07.001_bib0085","doi-asserted-by":"crossref","first-page":"558","DOI":"10.4049\/jimmunol.164.2.558","article-title":"Cutting edge: heat shock protein 60 is a putative endogenous ligand of the toll-like receptor-4 complex","volume":"164","author":"Ohashi","year":"2000","journal-title":"J. Immunol."},{"key":"10.1016\/j.semcancer.2016.07.001_bib0090","doi-asserted-by":"crossref","first-page":"15028","DOI":"10.1074\/jbc.M200497200","article-title":"Novel signal transduction pathway utilized by extracellular HSP70: role of toll-like receptor (TLR) 2 and TLR4","volume":"277","author":"Asea","year":"2002","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.semcancer.2016.07.001_bib0095","doi-asserted-by":"crossref","first-page":"7370","DOI":"10.1074\/jbc.M306793200","article-title":"Involvement of toll-like receptors 2 and 4 in cellular activation by high mobility group Box 1 protein","volume":"279","author":"Park","year":"2004","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.semcancer.2016.07.001_bib0100","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1126\/science.285.5428.736","article-title":"Cell activation and apoptosis by bacterial lipoproteins through toll-like receptor-2","volume":"285","author":"Aliprantis","year":"1999","journal-title":"Science"},{"key":"10.1016\/j.semcancer.2016.07.001_bib0105","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1038\/44605","article-title":"The Toll-like receptor 2 is recruited to macrophage phagosomes and discriminates between pathogens","volume":"401","author":"Underhill","year":"1999","journal-title":"Nature"},{"key":"10.1016\/j.semcancer.2016.07.001_bib0110","doi-asserted-by":"crossref","first-page":"1544","DOI":"10.1126\/science.291.5508.1544","article-title":"Induction of direct antimicrobial activity through mammalian toll-like receptors","volume":"291","author":"Thoma-Uszynski","year":"2001","journal-title":"Science"},{"key":"10.1016\/j.semcancer.2016.07.001_bib0115","doi-asserted-by":"crossref","first-page":"10","DOI":"10.4049\/jimmunol.169.1.10","article-title":"Cutting edge: role of Toll-like receptor 1 in mediating immune response to microbial lipoproteins","volume":"169","author":"Takeuchi","year":"2002","journal-title":"J. Immunol."},{"key":"10.1016\/j.semcancer.2016.07.001_bib0120","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1038\/35074106","article-title":"The innate immune response to bacterial flagellin is mediated by Toll-like receptor 5","volume":"410","author":"Hayashi","year":"2001","journal-title":"Nature"},{"key":"10.1016\/j.semcancer.2016.07.001_bib0125","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1038\/35099560","article-title":"Recognition of double-stranded RNA and activation of NF-kappaB by Toll-like receptor 3","volume":"413","author":"Alexopoulou","year":"2001","journal-title":"Nature"},{"key":"10.1016\/j.semcancer.2016.07.001_bib0130","doi-asserted-by":"crossref","first-page":"1526","DOI":"10.1126\/science.1093620","article-title":"Species-specific recognition of single-stranded RNA via toll-like receptor 7 and 8","volume":"303","author":"Heil","year":"2004","journal-title":"Science"},{"key":"10.1016\/j.semcancer.2016.07.001_bib0135","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1038\/ni758","article-title":"Small anti-viral compounds activate immune cells via the TLR7 MyD88-dependent signaling pathway","volume":"3","author":"Hemmi","year":"2002","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.semcancer.2016.07.001_bib0140","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1084\/jem.20050630","article-title":"RNA-associated autoantigens activate B cells by combined B cell antigen receptor\/Toll-like receptor 7 engagement","volume":"202","author":"Lau","year":"2005","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.semcancer.2016.07.001_bib0145","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1038\/35047123","article-title":"A toll-like receptor recognizes bacterial DNA","volume":"408","author":"Hemmi","year":"2000","journal-title":"Nature"},{"key":"10.1016\/j.semcancer.2016.07.001_bib0150","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1038\/416603a","article-title":"Chromatin-IgG complexes activate B cells by dual engagement of IgM and Toll-like receptors","volume":"416","author":"Leadbetter","year":"2002","journal-title":"Nature"},{"key":"10.1016\/j.semcancer.2016.07.001_bib0155","doi-asserted-by":"crossref","first-page":"6084","DOI":"10.4049\/jimmunol.1203245","article-title":"Identification of TLR10 as a key mediator of the inflammatory response to Listeria monocytogenes in intestinal epithelial cells and macrophages","volume":"191","author":"Regan","year":"2013","journal-title":"J. Immunol."},{"key":"10.1016\/j.semcancer.2016.07.001_bib0160","doi-asserted-by":"crossref","first-page":"3793","DOI":"10.1073\/pnas.1324266111","article-title":"Toll-like receptor 10 is involved in induction of innate immune responses to influenza virus infection","volume":"111","author":"Lee","year":"2014","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.semcancer.2016.07.001_bib0165","doi-asserted-by":"crossref","first-page":"E4478","DOI":"10.1073\/pnas.1410293111","article-title":"Human TLR10 is an anti-inflammatory pattern-recognition receptor","volume":"111","author":"Oosting","year":"2014","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.semcancer.2016.07.001_bib0170","doi-asserted-by":"crossref","first-page":"3834","DOI":"10.4049\/jimmunol.1502599","article-title":"TLR10 is a negative regulator of both myD88-dependent and -independent TLR signaling","volume":"196","author":"Jiang","year":"2016","journal-title":"J. Immunol."},{"key":"10.1016\/j.semcancer.2016.07.001_bib0175","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1006\/geno.1996.0632","article-title":"Molecular cloning of a human RP105 homologue and chromosomal localization of the mouse and human RP105 genes (Ly64 and LY64)","volume":"38","author":"Miura","year":"1996","journal-title":"Genomics"},{"key":"10.1016\/j.semcancer.2016.07.001_bib0180","doi-asserted-by":"crossref","first-page":"7043","DOI":"10.4049\/jimmunol.174.11.7043","article-title":"The radioprotective 105\/MD-1 complex links TLR2 and TLR4\/MD-2 in antibody response to microbial membranes","volume":"174","author":"Nagai","year":"2005","journal-title":"J. Immunol."},{"key":"10.1016\/j.semcancer.2016.07.001_bib0185","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1038\/ni1198","article-title":"Negative regulation of Toll-like receptor 4 signaling by the Toll-like receptor homolog RP105","volume":"6","author":"Divanovic","year":"2005","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.semcancer.2016.07.001_bib0190","doi-asserted-by":"crossref","first-page":"4199","DOI":"10.4049\/jimmunol.1100198","article-title":"Anti-CD180 (RP105) activates B cells to rapidly produce polyclonal Ig via a T cell and MyD88-independent pathway","volume":"187","author":"Chaplin","year":"2011","journal-title":"J. Immunol."},{"key":"10.1016\/j.semcancer.2016.07.001_bib0195","doi-asserted-by":"crossref","first-page":"2815","DOI":"10.1182\/blood.V92.8.2815","article-title":"RP105 is associated with MD-1 and transmits an activation signal in human B cells","volume":"92","author":"Miura","year":"1998","journal-title":"Blood"},{"key":"10.1016\/j.semcancer.2016.07.001_bib0200","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1126\/science.271.5252.1128","article-title":"IRAK: a kinase associated with the interleukin-1 receptor","volume":"271","author":"Cao","year":"1996","journal-title":"Science"},{"key":"10.1016\/j.semcancer.2016.07.001_bib0205","doi-asserted-by":"crossref","first-page":"1612","DOI":"10.1126\/science.278.5343.1612","article-title":"IRAK (Pelle) family member IRAK-2 and MyD88 as proximal mediators of IL-1 signaling","volume":"278","author":"Muzio","year":"1997","journal-title":"Science"},{"key":"10.1016\/j.semcancer.2016.07.001_bib0210","doi-asserted-by":"crossref","first-page":"2097","DOI":"10.1084\/jem.187.12.2097","article-title":"The human toll signaling pathway: divergence of nuclear factor kappaB and JNK\/SAPK activation upstream of tumor necrosis factor receptor-associated factor 6 (TRAF6)","volume":"187","author":"Muzio","year":"1998","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.semcancer.2016.07.001_bib0215","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/S0092-8674(02)00827-9","article-title":"IRAK-M is a negative regulator of Toll-like receptor signaling","volume":"110","author":"Kobayashi","year":"2002","journal-title":"Cell"},{"key":"10.1016\/j.semcancer.2016.07.001_bib0220","doi-asserted-by":"crossref","first-page":"19403","DOI":"10.1074\/jbc.274.27.19403","article-title":"IRAK-M is a novel member of the Pelle\/interleukin-1 receptor-associated kinase (IRAK) family","volume":"274","author":"Wesche","year":"1999","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.semcancer.2016.07.001_bib0225","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1084\/jem.189.7.1129","article-title":"Defective interleukin (IL)-18-mediated natural killer and T helper cell type 1 responses in IL-1 receptor-associated kinase (IRAK)-deficient mice","volume":"189","author":"Kanakaraj","year":"1999","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.semcancer.2016.07.001_bib0230","doi-asserted-by":"crossref","first-page":"978","DOI":"10.4049\/jimmunol.163.2.978","article-title":"Impaired cytokine signaling in mice lacking the IL-1 receptor-associated kinase","volume":"163","author":"Thomas","year":"1999","journal-title":"J. Immunol."},{"key":"10.1016\/j.semcancer.2016.07.001_bib0235","doi-asserted-by":"crossref","first-page":"5567","DOI":"10.1073\/pnas.082100399","article-title":"IRAK-4: a novel member of the IRAK family with the properties of an IRAK-kinase","volume":"99","author":"Li","year":"2002","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.semcancer.2016.07.001_bib0240","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1038\/nature736","article-title":"Severe impairment of interleukin-1 and Toll-like receptor signalling in mice lacking IRAK-4","volume":"416","author":"Suzuki","year":"2002","journal-title":"Nature"},{"key":"10.1016\/j.semcancer.2016.07.001_bib0245","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1038\/ni.1606","article-title":"Sequential control of Toll-like receptor-dependent responses by IRAK1 and IRAK2","volume":"9","author":"Kawagoe","year":"2008","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.semcancer.2016.07.001_bib0250","doi-asserted-by":"crossref","first-page":"1615","DOI":"10.1084\/jem.20090490","article-title":"A mutation in Irak2c identifies IRAK-2 as a central component of the TLR regulatory network of wild-derived mice","volume":"206","author":"Conner","year":"2009","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.semcancer.2016.07.001_bib0255","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1038\/nature09121","article-title":"Helical assembly in the MyD88-IRAK4-IRAK2 complex in TLR\/IL-1R signalling","volume":"465","author":"Lin","year":"2010","journal-title":"Nature"},{"key":"10.1016\/j.semcancer.2016.07.001_bib0260","doi-asserted-by":"crossref","first-page":"1981","DOI":"10.1016\/j.bcp.2010.06.020","article-title":"The interleukin-1 receptor-associated kinases: critical regulators of innate immune signalling","volume":"80","author":"Flannery","year":"2010","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.semcancer.2016.07.001_bib0265","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1016\/j.bbrc.2006.11.068","article-title":"Regulation of IRAK-4 kinase activity via autophosphorylation within its activation loop","volume":"352","author":"Cheng","year":"2007","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.semcancer.2016.07.001_bib0270","doi-asserted-by":"crossref","first-page":"13552","DOI":"10.1074\/jbc.M700548200","article-title":"IRAK-4 kinase activity is required for interleukin-1 (IL-1) receptor- and toll-like receptor 7-mediated signaling and gene expression","volume":"282","author":"Koziczak-Holbro","year":"2007","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.semcancer.2016.07.001_bib0275","doi-asserted-by":"crossref","first-page":"26748","DOI":"10.1074\/jbc.M400785200","article-title":"IRAK4 kinase activity is redundant for interleukin-1 (IL-1) receptor-associated kinase phosphorylation and IL-1 responsiveness","volume":"279","author":"Qin","year":"2004","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.semcancer.2016.07.001_bib0280","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1189\/jlb.0812401","article-title":"IRAK4 kinase activity is not required for induction of endotoxin tolerance but contributes to TLR2-mediated tolerance","volume":"94","author":"Xiong","year":"2013","journal-title":"J. Leukoc. Biol."},{"key":"10.1016\/j.semcancer.2016.07.001_bib0285","doi-asserted-by":"crossref","first-page":"307","DOI":"10.4049\/jimmunol.1201644","article-title":"Complete dependence on IRAK4 kinase activity in TLR2, but not TLR4 signaling pathways underlies decreased cytokine production and increased susceptibility to streptococcus pneumoniae infection in IRAK4 kinase-Inactive mice","volume":"190","author":"Pennini","year":"2012","journal-title":"J. Immunol."},{"key":"10.1016\/j.semcancer.2016.07.001_bib0290","doi-asserted-by":"crossref","first-page":"10865","DOI":"10.1074\/jbc.M113.544809","article-title":"Interleukin 1\/Toll-like receptor-induced autophosphorylation activates interleukin 1 receptor-associated kinase 4 and controls cytokine induction in a cell type-specific manner","volume":"289","author":"Cushing","year":"2014","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.semcancer.2016.07.001_bib0295","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/S0014-5793(99)00322-1","article-title":"Effects of IL-1 receptor-associated kinase (IRAK) expression on IL-1 signaling are independent of its kinase activity","volume":"448","author":"Knop","year":"1999","journal-title":"FEBS Lett."},{"issue":"Pt. 2","key":"10.1016\/j.semcancer.2016.07.001_bib0300","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1042\/bj3390227","article-title":"Overexpression of an enzymically inactive interleukin-1-receptor-associated kinase activates nuclear factor-kappaB","volume":"339","author":"Maschera","year":"1999","journal-title":"Biochem. J."},{"key":"10.1016\/j.semcancer.2016.07.001_bib0305","doi-asserted-by":"crossref","first-page":"1458","DOI":"10.1016\/j.molimm.2008.12.012","article-title":"The kinase activities of interleukin-1 receptor associated kinase (IRAK)-1 and 4 are redundant in the control of inflammatory cytokine expression in human cells","volume":"46","author":"Song","year":"2009","journal-title":"Mol. Immunol."},{"key":"10.1016\/j.semcancer.2016.07.001_bib0310","doi-asserted-by":"crossref","first-page":"2717","DOI":"10.4049\/jimmunol.1203268","article-title":"Two phases of inflammatory mediator production defined by the study of IRAK2 and IRAK1 knock-in mice","volume":"191","author":"Pauls","year":"2013","journal-title":"J. Immunol."},{"key":"10.1016\/j.semcancer.2016.07.001_bib0315","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1089\/jir.2010.0094","article-title":"The kinase activity of interleukin-1 receptor-associated kinase 2 is essential for lipopolysaccharide-mediated cytokine and chemokine mRNA stability and translation","volume":"31","author":"Yin","year":"2011","journal-title":"J. Interferon Cytokine Res."},{"key":"10.1016\/j.semcancer.2016.07.001_bib0320","doi-asserted-by":"crossref","first-page":"23688","DOI":"10.1074\/jbc.M111.248351","article-title":"Human interleukin-1 receptor-associated kinase-2 is essential for Toll-like receptor-mediated transcriptional and post-transcriptional regulation of tumor necrosis factor alpha","volume":"286","author":"Flannery","year":"2011","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.semcancer.2016.07.001_bib0325","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1084\/jem.20061523","article-title":"Essential role of IRAK-4 protein and its kinase activity in Toll-like receptor-mediated immune responses but not in TCR signaling","volume":"204","author":"Kawagoe","year":"2007","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.semcancer.2016.07.001_bib0330","doi-asserted-by":"crossref","first-page":"5227","DOI":"10.1074\/jbc.M309251200","article-title":"Sequential autophosphorylation steps in the interleukin-1 receptor-associated kinase-1 regulate its availability as an adapter in interleukin-1 signaling","volume":"279","author":"Kollewe","year":"2004","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.semcancer.2016.07.001_bib0335","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/S0092-8674(00)00126-4","article-title":"Activation of the IkappaB kinase complex by TRAF6 requires a dimeric ubiquitin-conjugating enzyme complex and a unique polyubiquitin chain","volume":"103","author":"Deng","year":"2000","journal-title":"Cell"},{"key":"10.1016\/j.semcancer.2016.07.001_bib0340","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1038\/cr.2010.170","article-title":"Expanding role of ubiquitination in NF-\u03baB signaling","volume":"21","author":"Liu","year":"2011","journal-title":"Cell Res."},{"key":"10.1016\/j.semcancer.2016.07.001_bib0345","doi-asserted-by":"crossref","first-page":"3214","DOI":"10.1038\/sj.onc.1210413","article-title":"Ubiquitin-mediated activation of TAK1 and IKK","volume":"26","author":"Adhikari","year":"2007","journal-title":"Oncogene"},{"key":"10.1016\/j.semcancer.2016.07.001_bib0350","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1038\/35085597","article-title":"TAK1 is a ubiquitin-dependent kinase of MKK and IKK","volume":"412","author":"Wang","year":"2001","journal-title":"Nature"},{"key":"10.1016\/j.semcancer.2016.07.001_bib0355","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1016\/S0092-8674(00)81698-0","article-title":"Structure of an IkappaBalpha\/NF-kappaB complex","volume":"95","author":"Jacobs","year":"1998","journal-title":"Cell"},{"key":"10.1016\/j.semcancer.2016.07.001_bib0360","doi-asserted-by":"crossref","first-page":"6758","DOI":"10.1038\/sj.onc.1209943","article-title":"NF-kappaB and the immune response","volume":"25","author":"Hayden","year":"2006","journal-title":"Oncogene"},{"key":"10.1016\/j.semcancer.2016.07.001_bib0365","doi-asserted-by":"crossref","first-page":"4304","DOI":"10.4049\/jimmunol.171.8.4304","volume":"171","author":"Sato","year":"2003","journal-title":"J. Immunol."},{"key":"10.1016\/j.semcancer.2016.07.001_bib0370","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/j.molcel.2004.08.008","article-title":"TAB2 and TAB3 activate the NF-kappaB pathway through binding to polyubiquitin chains","volume":"15","author":"Kanayama","year":"2004","journal-title":"Mol. Cell."},{"key":"10.1016\/j.semcancer.2016.07.001_bib0375","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1038\/ni921","article-title":"IKKepsilon and TBK1 are essential components of the IRF3 signaling pathway","volume":"4","author":"Fitzgerald","year":"2003","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.semcancer.2016.07.001_bib0380","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1182\/blood-2006-03-012948","article-title":"Over 20% of patients with chronic lymphocytic leukemia carry stereotyped receptors: pathogenetic implications and clinical correlations","volume":"109","author":"Stamatopoulos","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.semcancer.2016.07.001_bib0385","doi-asserted-by":"crossref","first-page":"4467","DOI":"10.1182\/blood-2011-11-393694","article-title":"Stereotyped B-cell receptors in one-third of chronic lymphocytic leukemia: a molecular classification with implications for targeted therapies","volume":"119","author":"Agathangelidis","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.semcancer.2016.07.001_bib0390","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1056\/NEJMoa1215637","article-title":"Targeting BTK with ibrutinib in relapsed chronic lymphocytic leukemia","volume":"369","author":"Byrd","year":"2013","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.semcancer.2016.07.001_bib0395","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1056\/NEJMoa1315226","article-title":"Idelalisib and rituximab in relapsed chronic lymphocytic leukemia","volume":"370","author":"Furman","year":"2014","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.semcancer.2016.07.001_bib0400","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1182\/blood-2006-12-060947","article-title":"Inhibition of glycogen synthase kinase-3 activity leads to epigenetic silencing of nuclear factor kappaB target genes and induction of apoptosis in chronic lymphocytic leukemia B cells","volume":"110","author":"Ougolkov","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.semcancer.2016.07.001_bib0405","doi-asserted-by":"crossref","first-page":"4681","DOI":"10.1182\/blood-2007-11-125278","article-title":"The NF-kappaB subunit Rel A is associated with in vitro survival and clinical disease progression in chronic lymphocytic leukemia and represents a promising therapeutic target","volume":"111","author":"Hewamana","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.semcancer.2016.07.001_bib0410","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1200\/JCO.2008.19.1114","article-title":"Rel a is an independent biomarker of clinical outcome in chronic lymphocytic leukemia","volume":"27","author":"Hewamana","year":"2009","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.semcancer.2016.07.001_bib0415","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1038\/leu.2014.196","article-title":"Recurrent mutations refine prognosis in chronic lymphocytic leukemia","volume":"29","author":"Baliakas","year":"2015","journal-title":"Leukemia"},{"key":"10.1016\/j.semcancer.2016.07.001_bib0420","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1084\/jem.20142009","article-title":"Functional loss of I\u03baB\u03b5 leads to NF-\u03baB deregulation in aggressive chronic lymphocytic leukemia","volume":"212","author":"Mansouri","year":"2015","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.semcancer.2016.07.001_bib0425","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1182\/blood-2010-05-284984","article-title":"The lymph node microenvironment promotes B-cell receptor signaling, NF-kappaB activation, and tumor proliferation in chronic lymphocytic leukemia","volume":"117","author":"Herishanu","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.semcancer.2016.07.001_bib0430","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1111\/bjh.12588","article-title":"Expression of ZAP70 in chronic lymphocytic leukaemia activates NF-\u03baB signalling","volume":"163","author":"Pede","year":"2013","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.semcancer.2016.07.001_bib0435","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1158\/1541-7786.MCR-10-0559","article-title":"STAT-3 activates NF-kappaB in chronic lymphocytic leukemia cells","volume":"9","author":"Liu","year":"2011","journal-title":"Mol. Cancer Res."},{"key":"10.1016\/j.semcancer.2016.07.001_bib0440","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1182\/blood-2003-02-0540","article-title":"Involvement of BAFF and APRIL in the resistance to apoptosis of B-CLL through an autocrine pathway","volume":"103","author":"Kern","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.semcancer.2016.07.001_bib0445","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1182\/blood-2006-06-027755","article-title":"BAFF and APRIL support chronic lymphocytic leukemia B-cell survival through activation of the canonical NF-kappaB pathway","volume":"109","author":"Endo","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.semcancer.2016.07.001_bib0450","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1182\/blood.V92.3.990","article-title":"Triggering of CD40 antigen inhibits fludarabine-induced apoptosis in B chronic lymphocytic leukemia cells","volume":"92","author":"Romano","year":"1998","journal-title":"Blood"},{"key":"10.1016\/j.semcancer.2016.07.001_bib0455","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1111\/j.1365-2141.2008.07475.x","article-title":"Expression and function of toll like receptors in chronic lymphocytic leukaemia cells","volume":"144","author":"Muzio","year":"2009","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.semcancer.2016.07.001_bib0460","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/j.niox.2008.04.017","article-title":"Stimulation of iNOS expression and apoptosis resistance in B-cell chronic lymphocytic leukemia (B-CLL) cells through engagement of Toll-like receptor 7 (TLR-7) and NF-kappaB activation","volume":"19","author":"Hammadi","year":"2008","journal-title":"Nitric Oxide"},{"key":"10.1016\/j.semcancer.2016.07.001_bib0465","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.3324\/haematol.10975","article-title":"Expression of functional toll-like receptors by B-chronic lymphocytic leukemia cells","volume":"92","author":"Grandjenette","year":"2007","journal-title":"Haematologica"},{"key":"10.1016\/j.semcancer.2016.07.001_bib0470","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1002\/ijc.24832","article-title":"Toll-like receptors on B-CLL cells: expression and functional consequences of their stimulation","volume":"126","author":"Rozkov\u00e1","year":"2010","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.semcancer.2016.07.001_bib0475","doi-asserted-by":"crossref","first-page":"1644","DOI":"10.3324\/haematol.2011.044792","article-title":"Toll-like receptor signaling pathway in chronic lymphocytic leukemia: distinct gene expression profiles of potential pathogenic significance in specific subsets of patients","volume":"96","author":"Arvaniti","year":"2011","journal-title":"Haematologica"},{"key":"10.1016\/j.semcancer.2016.07.001_bib0480","doi-asserted-by":"crossref","first-page":"1840","DOI":"10.1182\/blood.V94.6.1840","article-title":"Ig V gene mutation status and CD38 expression as novel prognostic indicators in chronic lymphocytic leukemia","volume":"94","author":"Damle","year":"1999","journal-title":"Blood"},{"key":"10.1016\/j.semcancer.2016.07.001_bib0485","doi-asserted-by":"crossref","first-page":"1848","DOI":"10.1182\/blood.V94.6.1848","article-title":"Unmutated Ig V(H) genes are associated with a more aggressive form of chronic lymphocytic leukemia","volume":"94","author":"Hamblin","year":"1999","journal-title":"Blood"},{"key":"10.1016\/j.semcancer.2016.07.001_bib0490","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1111\/j.1365-2141.2005.05775.x","article-title":"Differential expression of CD 180 and IgM by B-cell chronic lymphocytic leukaemia cells using mutated and unmutated immunoglobulin VH genes","volume":"131","author":"Porakishvili","year":"2005","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.semcancer.2016.07.001_bib0495","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1111\/j.1365-2141.2008.07475.x","article-title":"Expression and function of toll like receptors in chronic lymphocytic leukaemia cells","volume":"144","author":"Muzio","year":"2009","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.semcancer.2016.07.001_bib0500","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1158\/1078-0432.CCR-12-1922","article-title":"In vitro sensitivity of CLL cells to fludarabine may be modulated by the stimulation of Toll-like receptors","volume":"19","author":"Fonte","year":"2013","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.semcancer.2016.07.001_bib0505","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1016\/S0301-472X(00)00144-2","article-title":"Immunostimulatory CpG-oligonucleotides induce functional high affinity IL-2 receptors on B-CLL cells: costimulation with IL-2 results in a highly immunogenic phenotype","volume":"28","author":"Decker","year":"2000","journal-title":"Exp. Hematol."},{"key":"10.1016\/j.semcancer.2016.07.001_bib0510","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.2119\/molmed.2011.00480","article-title":"Distinct innate immunity pathways to activation and tolerance in subgroups of chronic lymphocytic leukemia with distinct immunoglobulin receptors","volume":"18","author":"Ntoufa","year":"2012","journal-title":"Mol. Med."},{"key":"10.1016\/j.semcancer.2016.07.001_bib0515","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1016\/j.leukres.2009.12.020","article-title":"The proliferative response to CpG-ODN stimulation predicts PFS, TTT and OS in patients with chronic lymphocytic leukemia","volume":"34","author":"Tarnani","year":"2010","journal-title":"Leuk. Res."},{"key":"10.1016\/j.semcancer.2016.07.001_bib0520","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1038\/sj.leu.2404417","article-title":"The Akt signaling pathway determines the different proliferative capacity of chronic lymphocytic leukemia B-cells from patients with progressive and stable disease","volume":"21","author":"Longo","year":"2007","journal-title":"Leukemia"},{"key":"10.1016\/j.semcancer.2016.07.001_bib0525","doi-asserted-by":"crossref","first-page":"3949","DOI":"10.1182\/blood-2009-11-254656","article-title":"MicroRNA and proliferation control in chronic lymphocytic leukemia: functional relationship between miR-221\/222 cluster and p27","volume":"115","author":"Frenquelli","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.semcancer.2016.07.001_bib0530","doi-asserted-by":"crossref","first-page":"5071","DOI":"10.1038\/onc.2010.248","article-title":"Dichotomy in NF-kappaB signaling and chemoresistance in immunoglobulin variable heavy-chain-mutated versus unmutated CLL cells upon CD40\/TLR9 triggering","volume":"29","author":"Tromp","year":"2010","journal-title":"Oncogene"},{"key":"10.1016\/j.semcancer.2016.07.001_bib0535","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1182\/blood.V95.3.999.003k10_999_1006","article-title":"Immunostimulatory CpG-oligonucleotides cause proliferation, cytokine production, and an immunogenic phenotype in chronic lymphocytic leukemia B cells","volume":"95","author":"Decker","year":"2000","journal-title":"Blood"},{"key":"10.1016\/j.semcancer.2016.07.001_bib0540","doi-asserted-by":"crossref","first-page":"901","DOI":"10.4049\/jimmunol.1403189","article-title":"TLR-9 and IL-15 synergy promotes the In vitro clonal expansion of chronic lymphocytic leukemia B cells","volume":"195","author":"Mongini","year":"2015","journal-title":"J. Immunol."},{"key":"10.1016\/j.semcancer.2016.07.001_bib0545","doi-asserted-by":"crossref","first-page":"e26056","DOI":"10.1371\/journal.pone.0026056","article-title":"Differentiation of chronic lymphocytic leukemia B cells into immunoglobulin secreting cells decreases LEF-1 expression","volume":"6","author":"Gutierrez","year":"2011","journal-title":"PLoS One"},{"issue":"292","key":"10.1016\/j.semcancer.2016.07.001_bib0550","article-title":"TLR9 ligand (CpG oligodeoxynucleotide) induces CLL B-Cells to differentiate into CD20(+) antibody-Secreting cells","volume":"5","author":"Ghamlouch","year":"2014","journal-title":"Front. Immunol."},{"key":"10.1016\/j.semcancer.2016.07.001_bib0555","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1038\/leu.2014.266","article-title":"In vitro induction of antibody secretion of primary B-cell chronic lymphocytic leukaemia cells","volume":"29","author":"Hoogeboom","year":"2014","journal-title":"Leukemia"},{"key":"10.1016\/j.semcancer.2016.07.001_bib0560","doi-asserted-by":"crossref","first-page":"3277","DOI":"10.1182\/blood-2013-11-539049","article-title":"Variable induction of PRDM1 and differentiation in chronic lymphocytic leukemia is associated with anergy","volume":"123","author":"Duckworth","year":"2014","journal-title":"Blood"},{"key":"10.1016\/j.semcancer.2016.07.001_bib0565","first-page":"1502297","article-title":"B cell anergy modulated by TLR1\/2 and the miR-17\u223c92 cluster underlies the indolent clinical course of chronic lymphocytic leukemia stereotyped subset #4","volume":"29","author":"Ntoufa","year":"2016","journal-title":"J. Immunol."},{"key":"10.1016\/j.semcancer.2016.07.001_bib0570","doi-asserted-by":"crossref","first-page":"1709","DOI":"10.1182\/blood-2013-10-529610","article-title":"Extracellular HMGB1 promotes differentiation of nurse-like cells in chronic lymphocytic leukemia","volume":"123","author":"Jia","year":"2014","journal-title":"Blood"},{"key":"10.1016\/j.semcancer.2016.07.001_bib0575","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1053\/j.seminoncol.2005.12.013","article-title":"Infectious complications of chronic lymphocytic leukemia","volume":"33","author":"Wadhwa","year":"2006","journal-title":"Semin. Oncol."},{"key":"10.1016\/j.semcancer.2016.07.001_bib0580","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.autrev.2007.02.014","article-title":"From normal to clonal B cells: chronic lymphocytic leukemia (CLL) at the crossroad between neoplasia and autoimmunity","volume":"7","author":"Ghia","year":"2007","journal-title":"Autoimmun. Rev."},{"key":"10.1016\/j.semcancer.2016.07.001_bib0585","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1182\/blood-2011-01-329870","article-title":"Lack of TIR8\/SIGIRR triggers progression of chronic lymphocytic leukemia in mouse models","volume":"118","author":"Bertilaccio","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.semcancer.2016.07.001_bib0590","doi-asserted-by":"crossref","first-page":"e60671","DOI":"10.1371\/journal.pone.0060671","article-title":"Characterization of the Toll-like receptor expression profile in human multiple myeloma cells","volume":"8","author":"Abdi","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.semcancer.2016.07.001_bib0595","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1182\/blood-2006-10-051482","article-title":"Plasma cells from multiple myeloma patients express B7-H1 (PD-L1) and increase expression after stimulation with IFN-{gamma} and TLR ligands via a MyD88-, TRAF6-, and MEK-dependent pathway","volume":"110","author":"Liu","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.semcancer.2016.07.001_bib0600","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.1038\/sj.leu.2404225","article-title":"Toll-like receptors mediate proliferation and survival of multiple myeloma cells","volume":"20","author":"Bohnhorst","year":"2006","journal-title":"Leukemia"},{"key":"10.1016\/j.semcancer.2016.07.001_bib0605","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1038\/sj.leu.2404226","article-title":"Pathogen-associated molecular patterns are growth and survival factors for human myeloma cells through Toll-like receptors","volume":"20","author":"Jego","year":"2006","journal-title":"Leukemia"},{"key":"10.1016\/j.semcancer.2016.07.001_bib0610","doi-asserted-by":"crossref","first-page":"4471","DOI":"10.4049\/jimmunol.0803113","article-title":"TLR3 ligand induces NF-{kappa}B activation and various fates of multiple myeloma cells depending on IFN-{alpha} production","volume":"182","author":"Chiron","year":"2009","journal-title":"J. Immunol."},{"key":"10.1016\/j.semcancer.2016.07.001_bib0615","doi-asserted-by":"crossref","first-page":"e96608","DOI":"10.1371\/journal.pone.0096608","article-title":"Toll-like receptor (TLR)-1\/2 triggering of multiple myeloma cells modulates their adhesion to bone marrow stromal cells and enhances bortezomib-induced apoptosis","volume":"9","author":"Abdi","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.semcancer.2016.07.001_bib0620","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1016\/j.yexmp.2010.08.003","article-title":"Differential expression of Toll-like receptors in follicular lymphoma, diffuse large B-cell lymphoma and peripheral T-cell lymphoma, Exp","volume":"89","author":"Smith","year":"2010","journal-title":"Mol. Pathol."},{"key":"10.1016\/j.semcancer.2016.07.001_bib0625","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1002\/cncr.27792","article-title":"Toll-like receptor-4 signaling in mantle cell lymphoma: effects on tumor growth and immune evasion","volume":"119","author":"Wang","year":"2013","journal-title":"Cancer"},{"key":"10.1016\/j.semcancer.2016.07.001_bib0630","doi-asserted-by":"crossref","first-page":"1460","DOI":"10.3324\/haematol.2014.119933","article-title":"Toll-like receptor stimulation in splenic marginal zone lymphoma can modulate cell signaling, activation and proliferation","volume":"100","author":"Fonte","year":"2015","journal-title":"Haematologica"},{"key":"10.1016\/j.semcancer.2016.07.001_bib0635","doi-asserted-by":"crossref","first-page":"1490","DOI":"10.1158\/1078-0432.CCR-04-1890","article-title":"B-cell lymphomas differ in their responsiveness to CpG oligodeoxynucleotides","volume":"11","author":"Jahrsd\u00f6rfer","year":"2005","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.semcancer.2016.07.001_bib0640","doi-asserted-by":"crossref","first-page":"4518","DOI":"10.4049\/jimmunol.1302102","article-title":"Heterogeneous functional effects of concomitant B cell receptor and TLR stimulation in chronic lymphocytic leukemia with mutated versus unmutated Ig genes","volume":"192","author":"Chatzouli","year":"2014","journal-title":"J. Immunol."},{"key":"10.1016\/j.semcancer.2016.07.001_bib0645","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1038\/nature09671","article-title":"Oncogenically active MYD88 mutations in human lymphoma","volume":"470","author":"Ngo","year":"2011","journal-title":"Nature"},{"key":"10.1016\/j.semcancer.2016.07.001_bib0650","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1111\/j.1365-2796.2009.02083.x","article-title":"Infectious agents and lymphoma development: molecular and clinical aspects","volume":"265","author":"Ferreri","year":"2009","journal-title":"J. Intern. Med."},{"key":"10.1016\/j.semcancer.2016.07.001_bib0655","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1016\/j.humimm.2011.07.307","article-title":"Association of polymorphisms in TLR genes and in genes of the Toll-like receptor signaling pathway with cancer risk","volume":"72","author":"Kutikhin","year":"2011","journal-title":"Hum. Immunol."},{"key":"10.1016\/j.semcancer.2016.07.001_bib0660","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/S1470-2045(05)70434-4","article-title":"Genetic variation in TNF and IL10 and risk of non-Hodgkin lymphoma: a report from the InterLymph consortium","volume":"7","author":"Rothman","year":"2006","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.semcancer.2016.07.001_bib0665","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1080\/1042819050086451","article-title":"Association study of a functional Toll-like receptor 4 polymorphism with susceptibility to gastric mucosa-associated lymphoid tissue lymphoma","volume":"46","author":"Hellmig","year":"2005","journal-title":"Leuk. Lymphoma"},{"key":"10.1016\/j.semcancer.2016.07.001_bib0670","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1093\/carcin\/bgn262","article-title":"A pooled investigation of Toll-like receptor gene variants and risk of non-Hodgkin lymphoma","volume":"30","author":"Purdue","year":"2009","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.semcancer.2016.07.001_bib0675","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1038\/sj.gene.6364337","article-title":"Gene polymorphisms in Toll-like receptors, interleukin-10, and interleukin-10 receptor alpha and lymphoma risk","volume":"7","author":"Nieters","year":"2006","journal-title":"Genes Immun."},{"key":"10.1016\/j.semcancer.2016.07.001_bib0680","article-title":"Toll-like receptor gene polymorphisms and the risk of lymphoma","volume":"67","author":"Nieters","year":"2007","journal-title":"Cancer Res."},{"key":"10.1016\/j.semcancer.2016.07.001_bib0685","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1097\/MCG.0b013e31828a6e93","article-title":"TLR4 D299G polymorphism modulates cytokine expression in ulcerative colitis","volume":"47","author":"Meena","year":"2013","journal-title":"J. Clin. Gastroenterol."},{"key":"10.1016\/j.semcancer.2016.07.001_bib0690","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1111\/j.1365-2141.2006.06141.x","article-title":"Polymorphisms in innate immunity genes and risk of non-Hodgkin lymphoma","volume":"134","author":"Forrest","year":"2006","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.semcancer.2016.07.001_bib0695","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1159\/000323880","article-title":"A nonsynonymous polymorphism of IRAK4 associated with increased prevalence of gram-positive infection and decreased response to toll-like receptor ligands","volume":"3","author":"Sutherland","year":"2011","journal-title":"J. Innate Immun."},{"issue":"338","key":"10.1016\/j.semcancer.2016.07.001_bib0700","article-title":"IRAK4 and TLR3 sequence variants may alter Breast cancer risk among african-American women","volume":"4","author":"Yeyeodu","year":"2013","journal-title":"Front. Immunol."},{"key":"10.1016\/j.semcancer.2016.07.001_bib0705","doi-asserted-by":"crossref","first-page":"23123","DOI":"10.1074\/jbc.M113.492934","article-title":"A coding IRAK2 protein variant compromises Toll-like receptor (TLR) signaling and is associated with colorectal cancer survival","volume":"289","author":"Wang","year":"2014","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.semcancer.2016.07.001_bib0710","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1038\/sj.leu.2404061","article-title":"Immunomodulatory effects of Toll-like receptor-7 activation on chronic lymphocytic leukemia cells","volume":"20","author":"Spaner","year":"2006","journal-title":"Leukemia"},{"key":"10.1016\/j.semcancer.2016.07.001_bib0715","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1038\/sj.leu.2404456","article-title":"Toll-like receptor agonists in the treatment of chronic lymphocytic leukemia","volume":"21","author":"Spaner","year":"2007","journal-title":"Leukemia"},{"key":"10.1016\/j.semcancer.2016.07.001_bib0720","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1189\/jlb.0604373","article-title":"Immunostimulatory oligodeoxynucleotides induce apoptosis of B cell chronic lymphocytic leukemia cells","volume":"77","author":"Jahrsd\u00f6rfer","year":"2005","journal-title":"J. Leukoc. Biol."},{"key":"10.1016\/j.semcancer.2016.07.001_bib0725","doi-asserted-by":"crossref","first-page":"5041","DOI":"10.1182\/blood-2009-03-213363","article-title":"Toll-like receptor 9 signaling by CpG-B oligodeoxynucleotides induces an apoptotic pathway in human chronic lymphocytic leukemia B cells","volume":"115","author":"Liang","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.semcancer.2016.07.001_bib0730","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1038\/leu.2009.195","article-title":"A phase I/II trial of TLR-7 agonist immunotherapy in chronic lymphocytic leukemia","volume":"24","author":"Spaner","year":"2009","journal-title":"Leukemia"},{"key":"10.1016\/j.semcancer.2016.07.001_bib0735","doi-asserted-by":"crossref","first-page":"211","DOI":"10.3109\/10428194.2011.608451","article-title":"Phase I clinical trial of CpG oligonucleotide 7909 (PF-03512676) in patients with previously treated chronic lymphocytic leukemia","volume":"53","author":"Zent","year":"2011","journal-title":"Leuk. Lymphoma"},{"key":"10.1016\/j.semcancer.2016.07.001_bib0740","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1182\/asheducation-2014.1.125","article-title":"BCR pathway inhibition as therapy for chronic lymphocytic leukemia and lymphoplasmacytic lymphoma","volume":"2014","author":"Wiestner","year":"2014","journal-title":"Hematol. Am. Soc. Hematol. Educ. Program."},{"key":"10.1016\/j.semcancer.2016.07.001_bib0745","doi-asserted-by":"crossref","first-page":"1970","DOI":"10.1016\/j.molimm.2009.03.010","article-title":"Role of phosphoinositide 3-kinase p110 delta in TLR4- and TLR9-mediated B cell cytokine production and differentiation","volume":"46","author":"Dil","year":"2009","journal-title":"Mol. Immunol."},{"key":"10.1016\/j.semcancer.2016.07.001_bib0750","doi-asserted-by":"crossref","first-page":"3635","DOI":"10.4049\/jimmunol.176.6.3635","article-title":"Bruton's tyrosine kinase is required for TLR2 and TLR4-induced TNF but not IL-6, production","volume":"176","author":"Horwood","year":"2006","journal-title":"J. Immunol."},{"key":"10.1016\/j.semcancer.2016.07.001_bib0755","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1097\/01.cji.0000211304.60126.8f","article-title":"Oligodeoxynucleotide CpG 7909 delivered as intravenous infusion demonstrates immunologic modulation in patients with previously treated non-Hodgkin lymphoma","volume":"29","author":"Link","year":"2006","journal-title":"J. Immunother."},{"key":"10.1016\/j.semcancer.2016.07.001_bib0760","doi-asserted-by":"crossref","first-page":"2493","DOI":"10.4049\/jimmunol.179.4.2493","article-title":"Lymphoma immunotherapy with CpG oligodeoxynucleotides requires TLR9 either in the host or in the tumor itself","volume":"179","author":"Li","year":"2007","journal-title":"J. Immunol."},{"key":"10.1016\/j.semcancer.2016.07.001_bib0765","doi-asserted-by":"crossref","first-page":"4324","DOI":"10.1200\/JCO.2010.28.9793","article-title":"In situ vaccination with a TLR9 agonist induces systemic lymphoma regression: a phase I\/II study","volume":"28","author":"Brody","year":"2010","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.semcancer.2016.07.001_bib0770","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1586\/erv.11.6","article-title":"Targeting malignant B cells as antigen-presenting cells: TLR-9 agonist induces systemic regression of lymphoma","volume":"10","author":"Klein-Gonz\u00e1lez","year":"2014","journal-title":"Expert Rev. Vaccines"},{"key":"10.1016\/j.semcancer.2016.07.001_bib0775","doi-asserted-by":"crossref","first-page":"5108","DOI":"10.1021\/jm900730r","article-title":"Modifications incorporated in CpG motifs of oligodeoxynucleotides lead to antagonist activity of toll-like receptors 7 and 9","volume":"52","author":"Yu","year":"2009","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.semcancer.2016.07.001_bib0780","unstructured":"ClinicalTrial gov website, ed., Dose Escalation Study in Patients With Relapsed or Refractory DLBCL and MyD88 L265P Mutation: https:\/\/clinicaltrials.gov\/ct2\/show\/NCT02252146, (2016) 1."},{"key":"10.1016\/j.semcancer.2016.07.001_bib0785","doi-asserted-by":"crossref","first-page":"1222","DOI":"10.1182\/blood-2012-12-475111","article-title":"A mutation in MYD88 (L265P) supports the survival of lymphoplasmacytic cells by activation of Bruton tyrosine kinase in Waldenstr\u00f6m macroglobulinemia","volume":"122","author":"Yang","year":"2013","journal-title":"Blood"},{"key":"10.1016\/j.semcancer.2016.07.001_bib0790","doi-asserted-by":"crossref","first-page":"2189","DOI":"10.1084\/jem.20151074","article-title":"Selective interleukin-1 receptor-associated kinase 4 inhibitors for the treatment of autoimmune disorders and lymphoid malignancy","volume":"212","author":"Kelly","year":"2015","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.semcancer.2016.07.001_bib0795","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1016\/S1471-4906(03)00115-7","article-title":"The Toll-IL-1 receptor adaptor family grows to five members","volume":"24","author":"O'Neill","year":"2003","journal-title":"Trends Immunol."}],"container-title":["Seminars in Cancer Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1044579X16300244?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1044579X16300244?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,8,19]],"date-time":"2023-08-19T05:13:50Z","timestamp":1692422030000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1044579X16300244"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,8]]},"references-count":159,"alternative-id":["S1044579X16300244"],"URL":"https:\/\/doi.org\/10.1016\/j.semcancer.2016.07.001","relation":{},"ISSN":["1044-579X"],"issn-type":[{"value":"1044-579X","type":"print"}],"subject":[],"published":{"date-parts":[[2016,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Toll-like receptors signaling: A complex network for NF-\u03baB activation in B-cell lymphoid malignancies","name":"articletitle","label":"Article Title"},{"value":"Seminars in Cancer Biology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.semcancer.2016.07.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}